Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Core Laboratories Inc. before investing.

In this article, we go over a few key elements for understanding Core Laboratories Inc.’s stock price such as:

• Core Laboratories Inc.’s current stock price and volume
• Why Core Laboratories Inc.’s stock price changed recently
• Upgrades and downgrades for CLB from analysts
• CLB’s stock price momentum as measured by its relative strength

About Core Laboratories Inc. (CLB)

Before we jump into Core Laboratories Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.

Want to learn more about Core Laboratories Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Core Laboratories Inc..

Core Laboratories Inc.’s Stock Price as of Market Close

As of November 26, 2025, 4:00 PM, CST, Core Laboratories Inc.’s stock price was $14.950.

Core Laboratories Inc. is down 0.6% from its previous closing price of $15.040.

During the last market session, Core Laboratories Inc.’s stock traded between $14.890 and $15.270. Currently, there are approximately 46.26 million shares outstanding for Core Laboratories Inc..

Core Laboratories Inc.’s price-earnings (P/E) ratio is currently at 22.0, which is high compared to the Energy Equipment & Services industry median of 17.1. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Core Laboratories Inc. Stock Price History

Core Laboratories Inc.’s (CLB) price is currently down 6.21% so far this month.

During the month of November, Core Laboratories Inc.’s stock price has reached a high of $16.550 and a low of $13.720.

Over the last year, Core Laboratories Inc. has hit prices as high as $21.200 and as low as $9.720. Year to date, Core Laboratories Inc.’s stock is down 13.63%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Core Laboratories Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 26, 2025, there was 1 analyst who downgraded Core Laboratories Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Core Laboratories Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Core Laboratories Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Core Laboratories Inc.’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Core Laboratories Inc. (CLB) by visiting AAII Stock Evaluator.

Relative Price Strength of Core Laboratories Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 26, 2025, Core Laboratories Inc. has a weighted four-quarter relative price strength of -2.20%, which translates to a Momentum Score of 52 and is considered to be Average.

Want to learn more about how Core Laboratories Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Core Laboratories Inc. Stock Price: Bottom Line

As of November 26, 2025, Core Laboratories Inc.’s stock price is $14.950, which is down 0.6% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Core Laboratories Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.